(Updated - May 12, 2020 5:54 AM EDT)JPMorgan analyst Chris Schott resumes coverage on Abbvie (NYSE: ABBV) with an Overweight ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE